- Home
- ALV vs CORT Comparison
ALV vs CORT Comparison
Compare ALV & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALV
- CORT
- Stock Information
- Founded
- ALV 1953
- CORT 1998
- Country
- ALV Sweden
- CORT United States
- Employees
- ALV N/A
- CORT N/A
- Industry
- ALV Auto Parts:O.E.M.
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ALV Consumer Discretionary
- CORT Health Care
- Exchange
- ALV Nasdaq
- CORT Nasdaq
- Market Cap
- ALV 7.2B
- CORT 7.1B
- IPO Year
- ALV 1997
- CORT N/A
- Fundamental
- Price
- ALV $100.79
- CORT $78.69
- Analyst Decision
- ALV Buy
- CORT Strong Buy
- Analyst Count
- ALV 11
- CORT 4
- Target Price
- ALV $116.27
- CORT $142.00
- AVG Volume (30 Days)
- ALV 508.7K
- CORT 1.1M
- Earning Date
- ALV 07-18-2025
- CORT 05-05-2025
- Dividend Yield
- ALV 2.79%
- CORT N/A
- EPS Growth
- ALV 35.84
- CORT 8.36
- EPS
- ALV 8.68
- CORT 1.14
- Revenue
- ALV $10,353,000,000.00
- CORT $685,446,000.00
- Revenue This Year
- ALV N/A
- CORT $35.85
- Revenue Next Year
- ALV $3.78
- CORT $35.22
- P/E Ratio
- ALV $11.55
- CORT $68.97
- Revenue Growth
- ALV N/A
- CORT 30.93
- 52 Week Low
- ALV $75.49
- CORT $27.30
- 52 Week High
- ALV $129.38
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ALV 65.14
- CORT 62.98
- Support Level
- ALV $100.71
- CORT $74.34
- Resistance Level
- ALV $102.83
- CORT $75.50
- Average True Range (ATR)
- ALV 1.58
- CORT 3.21
- MACD
- ALV 0.04
- CORT 0.50
- Stochastic Oscillator
- ALV 77.85
- CORT 92.19
About ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.